S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

MYOG

Myogen (MYOG)

Myogen

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MYOG

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
18/11/2006	08:02	Business Wire	Gilead Sciences Completes Acquisition of Myogen	NASDAQ:MYOG	Myogen
07/11/2006	00:00	Business Wire	Darusentan Data to Be Presented at AHA 2006 -- Chicago	NASDAQ:MYOG	Myogen
18/10/2006	06:00	Business Wire	Darusentan Data to Be Presented at ISH 2006 -- Fukuoka, Japan	NASDAQ:MYOG	Myogen
10/10/2006	22:00	Business Wire	Four Ambrisentan Studies to Be Presented at Chest 2006 -- Salt Lake City	NASDAQ:MYOG	Myogen
03/10/2006	02:11	PR Newswire (US)	Seven Summits Research Releases Comments on GOOG, ABX, HET, CBS, and MYOG	NASDAQ:MYOG	Myogen
02/10/2006	21:00	Business Wire	Gilead Sciences to Acquire Myogen, Inc. for $2.5 Billion	NASDAQ:MYOG	Myogen
20/09/2006	22:30	Business Wire	Myogen to Present at the UBS Global Life Sciences Conference	NASDAQ:MYOG	Myogen
07/09/2006	22:00	Business Wire	Myogen Initiates Open-Label Phase 3 Clinical Trial of Ambrisentan in Patients with Pulmonary Hypertension	NASDAQ:MYOG	Myogen
06/09/2006	22:00	Business Wire	The American Lung Association and Myogen Announce Pulmonary Arterial Hypertension Educational Partnership	NASDAQ:MYOG	Myogen
08/08/2006	06:00	Business Wire	Myogen Reports 2006 Second Quarter Results	NASDAQ:MYOG	Myogen
25/07/2006	21:45	Business Wire	Myogen to Announce 2006 Second Quarter Results on August 7, 2006	NASDAQ:MYOG	Myogen
11/07/2006	22:30	Business Wire	Myogen Announces Extension of Drug Discovery Collaboration	NASDAQ:MYOG	Myogen
08/06/2006	21:30	Business Wire	Myogen to Present at the Goldman Sachs Global Healthcare Conference	NASDAQ:MYOG	Myogen
05/06/2006	22:01	Business Wire	Myogen Initiates Phase 3 Clinical Trial of Darusentan in Patients with Resistant Hypertension	NASDAQ:MYOG	Myogen
24/05/2006	20:30	Business Wire	Ambrisentan Phase 3 ARIES-2 PAH Data Presented At ATS 2006 -- San Diego; Significant Improvement in Six-Minute Walk Distance an	NASDAQ:MYOG	Myogen
08/05/2006	21:00	Business Wire	Myogen Reports 2006 First Quarter Results	NASDAQ:MYOG	Myogen
04/05/2006	06:00	Business Wire	Myogen Reports Results for the Integrated Analysis of ARIES-1 and ARIES-2 Pivotal Trials of Ambrisentan in Pulmonary Arterial H	NASDAQ:MYOG	Myogen
21/04/2006	21:00	Business Wire	Myogen to Announce 2006 First Quarter Results on May 8, 2006	NASDAQ:MYOG	Myogen
20/04/2006	06:00	Business Wire	Myogen to Present at the Leerink Swann Vascular Modlulation Conference	NASDAQ:MYOG	Myogen
11/04/2006	02:36	PR Newswire (US)	Seven Summits Research releases comments on AAPL, EBAY, HAL, MYOG, and URBN	NASDAQ:MYOG	Myogen
10/04/2006	21:00	Business Wire	Myogen Reports Positive Top Line Results for Second Ambrisentan Pivotal Phase 3 Trial in Pulmonary Arterial Hypertension; ARIES	NASDAQ:MYOG	Myogen
10/03/2006	02:57	PR Newswire (US)	Seven Summits Research Releases Comments on MRVL, DELL, SGP, GENZ, and MYOG	NASDAQ:MYOG	Myogen
10/03/2006	00:00	Business Wire	Ambrisentan Receives FDA Fast Track Designation for PAH Development	NASDAQ:MYOG	Myogen
07/03/2006	08:10	Business Wire	Myogen Reports 2005 Results	NASDAQ:MYOG	Myogen
03/03/2006	00:00	Business Wire	Ambrisentan ARIES-2 Data to Be Presented at ATS 2006 -- San Diego	NASDAQ:MYOG	Myogen
01/03/2006	08:00	Business Wire	Myogen to Present at the Citigroup Small & Mid-Cap Conference	NASDAQ:MYOG	Myogen
14/02/2006	00:30	PR Newswire (US)	Myogen Reports Positive Top Line Results for Ambrisentan LFT Rescue Study In Pulmonary Arterial Hypertension	NASDAQ:MYOG	Myogen
07/02/2006	02:12	PR Newswire (US)	NASDAQ Hosts First-Ever Investor Conference in London for Small Cap Companies	NASDAQ:MYOG
07/02/2006	00:00	PR Newswire (US)	Myogen to Announce 2005 Results on March 6, 2006	NASDAQ:MYOG	Myogen
03/02/2006	08:30	PR Newswire (US)	Myogen Announces Sale of Myogen GmbH	NASDAQ:MYOG	Myogen

Showing the most relevant articles for your search:NASDAQ:MYOG

1 2 3 4 Next >>

Commonwealth Bank Of Aus...

Newcrest Mining

Gold vs US Dollar

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions